Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Research and development spending
3Y CAGR
-1.0%/yr
vs -3.4%/yr prior
5Y CAGR
-5.7%/yr
Recent acceleration
Acceleration
+2.3pp
Accelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.62M | -8.9% |
| 2025 | $5.07M | -20.7% |
| 2024 | $6.40M | +34.1% |
| 2023 | $4.77M | -28.9% |
| 2022 | $6.70M | +8.3% |
| 2021 | $6.19M | +41.3% |
| 2020 | $4.38M | -20.0% |
| 2019 | $5.47M | -19.7% |
| 2018 | $6.81M | +326.5% |
| 2017 | $1.60M | - |